Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with no approved treatment. Resmetirom is an oral, liver-directed, thyroid hormone receptor beta–selective agonist in development for ...
Nearly 60% of randomized trial abstracts were improved after peer review, according to blinded independent reviewers. Among abstracts that were eventually published in top medical journals, 72% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback